Skip to main content

Advertisement

Log in

Drug interactions in the treatment of Parkinson's disease

  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract.

In recent years, the antiparkinsonian drug regime has become increasingly complicated. A wide range of antiparkinson agents is meanwhile available. Combination therapies may unfortunately induce interactions up to the point of life-threatening events. The potential of drug-drug interactions must be taken into account before starting a patient on combination treatment. Moreover, the frequent multimorbidity of patients with Parkinson's disease necessitates the application of additional drugs. A general overview is difficult to maintain because of the countless number of possible interactions. Cautious proceeding is certainly indicated in particular cases. The most common interactions will be discussed below. We should bear in mind that many of the interactions related to drug combinations are unknown yet.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jost, W., Brück, C. Drug interactions in the treatment of Parkinson's disease. J Neurol 249 (Suppl 3), iii24–iii29 (2002). https://doi.org/10.1007/s00415-002-1305-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-002-1305-0

Navigation